Brady Todd C has filed 23 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 1880510 shares of Aldeyra Therapeutics, Inc. ($ALDX) on March 27, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | A | Stock Option (right to buy) | 1880510 | $0.00 | 1,880,510.0000 | 60,162,773 | 9999.99% | 3.13% |
| March 27, 2026 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | A | Bonus Units | 632318 | $0.00 | 632,318.0000 | 60,162,773 | 9999.99% | 1.05% |
| Dec. 17, 2025 | Evoke Pharma Inc | $EVOK | Brady Todd C | Not found | D | Stock Option (Right to Buy) | 1187 | $0.00 | 0.0000 | 2,557,408 | 100.00% | 0.05% |
| Dec. 16, 2025 | Evoke Pharma Inc | $EVOK | Brady Todd C | Not found | U | Common Stock | 27 | $0.00 | 0.0000 | 2,557,408 | 100.00% | 0.00% |
| Dec. 17, 2025 | Evoke Pharma Inc | $EVOK | Brady Todd C | Not found | D | Stock Option (Right to Buy) | 1218 | $0.00 | 0.0000 | 2,557,408 | 100.00% | 0.05% |
| Dec. 17, 2025 | Evoke Pharma Inc | $EVOK | Brady Todd C | Not found | D | Stock Option (Right to Buy) | 5833 | $0.00 | 0.0000 | 2,557,408 | 100.00% | 0.23% |
| May 21, 2025 | Evoke Pharma Inc | $EVOK | Brady Todd C | Not found | A | Stock Option (Right to Buy) | 1187 | $0.00 | 8,238.0000 | 1,905,072 | 16.83% | 0.06% |
| March 4, 2025 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | A | Stock Option (right to buy) | 809710 | $0.00 | 809,710.0000 | 59,708,654 | 9999.99% | 1.36% |
| Jan. 28, 2025 | Evoke Pharma Inc | $EVOK | Brady Todd C | Not found | A | Stock Option (Right to Buy) | 5833 | $0.00 | 5,833.0000 | 1,905,072 | 9999.99% | 0.31% |
| May 22, 2024 | Evoke Pharma Inc | $EVOK | Brady Todd C | Not found | A | Stock Option (Right to Buy) | 14625 | $0.00 | 14,625.0000 | 278,558 | 9999.99% | 5.25% |
| March 12, 2024 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | S | Common Stock | 85324 | $3.05 | 1,471,298.0000 | 0 | 5.48% | 0.00% |
| March 9, 2024 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | A | Stock Option (right to buy) | 1081201 | $0.00 | 1,081,201.0000 | 0 | 9999.99% | 0.00% |
| March 11, 2024 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | S | Common Stock | 97914 | $3.27 | 1,556,622.0000 | 0 | 5.92% | 0.00% |
| Sept. 7, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | M | Stock Option (right to buy) | 48021 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 7, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | M | Common Stock | 192084 | $0.55 | 1,647,369.0000 | 0 | 13.20% | 0.00% |
| Sept. 7, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | M | Common Stock | 32953 | $0.55 | 1,680,322.0000 | 0 | 2.00% | 0.00% |
| Sept. 7, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | M | Common Stock | 48021 | $0.55 | 1,728,343.0000 | 0 | 2.86% | 0.00% |
| Sept. 7, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | F | Common Stock | 73807 | $7.22 | 1,654,536.0000 | 0 | 4.27% | 0.00% |
| Sept. 7, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | M | Stock Option (right to buy) | 192084 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 7, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | M | Stock Option (right to buy) | 32953 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 10, 2023 | Evoke Pharma Inc | $EVOK | Brady Todd C | Director | A | Stock Option (Right to Buy) | 14625 | $0.00 | 14,625.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Brady Todd C | President and CEO | A | Common Stock | 238750 | $0.00 | 1,455,285.0000 | 0 | 19.63% | 0.00% |